Cargando…

Synthesis, antimicrobial, and antiproliferative activities of substituted phenylfuranylnicotinamidines

This research work deals with the design and synthesis of a series of substituted phenylfuranylnicotinamidines 4a–i. Facile preparation of the target compounds was achieved by Suzuki coupling-based synthesis of the nitrile precursors 3a–i, followed by their conversion to the corresponding nicotinami...

Descripción completa

Detalles Bibliográficos
Autores principales: Youssef, Magdy M, Arafa, Reem K, Ismail, Mohamed A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795586/
https://www.ncbi.nlm.nih.gov/pubmed/27042005
http://dx.doi.org/10.2147/DDDT.S102128
_version_ 1782421625779519488
author Youssef, Magdy M
Arafa, Reem K
Ismail, Mohamed A
author_facet Youssef, Magdy M
Arafa, Reem K
Ismail, Mohamed A
author_sort Youssef, Magdy M
collection PubMed
description This research work deals with the design and synthesis of a series of substituted phenylfuranylnicotinamidines 4a–i. Facile preparation of the target compounds was achieved by Suzuki coupling-based synthesis of the nitrile precursors 3a–i, followed by their conversion to the corresponding nicotinamidines 4a–i utilizing LiN(TMS)(2). The antimicrobial activities of the newly synthesized nicotinamidine derivatives were evaluated against the Gram-negative bacterial strains Escherichia coli and Pseudomonas aeruginosa as well as the Gram-positive bacterial strains Staphylococcus aureus and Bacillus megaterium. The minimum inhibitory concentration values of nicotinamidines against all tested microorganisms were in the range of 10–20 μM. In specific, compounds 4a and 4b showed excellent minimum inhibitory concentration values of 10 μM against Staphylococcus aureus bacterial strain and were similar to ampicillin as an antibacterial reference. On the other hand, selected nicotinamidine derivatives were biologically screened for their cytotoxic activities against a panel of 60 cell lines representing nine types of human cancer at a single high dose at National Cancer Institute, Bethesda, MD, USA. Nicotinamidines showing promising activities were further assessed in a five-dose screening assay to determine their compound concentration causing 50% growth inhibition of tested cell (GI(50)), compound concentration causing 100% growth inhibition of tested cell (TGI), and compound concentration causing 50% lethality of tested cell (LC(50)) values. Structure-activity relationship studies demonstrated that the activity of members of this series can be modulated from cytostatic to cytotoxic based on the substitution pattern/nature on the terminal phenyl ring. The most active compound was found to be 4e displaying a submicromolar GI(50) value of 0.83 μM, with TGI and LC(50) values of 2.51 and 100 μM, respectively. Finally, the possible underlying mechanism of action of this series of compounds was investigated by determining their nuclease-like DNA degradation ability in addition to their antioxidant power and all monocations proved to be effective in all assays.
format Online
Article
Text
id pubmed-4795586
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-47955862016-04-01 Synthesis, antimicrobial, and antiproliferative activities of substituted phenylfuranylnicotinamidines Youssef, Magdy M Arafa, Reem K Ismail, Mohamed A Drug Des Devel Ther Original Research This research work deals with the design and synthesis of a series of substituted phenylfuranylnicotinamidines 4a–i. Facile preparation of the target compounds was achieved by Suzuki coupling-based synthesis of the nitrile precursors 3a–i, followed by their conversion to the corresponding nicotinamidines 4a–i utilizing LiN(TMS)(2). The antimicrobial activities of the newly synthesized nicotinamidine derivatives were evaluated against the Gram-negative bacterial strains Escherichia coli and Pseudomonas aeruginosa as well as the Gram-positive bacterial strains Staphylococcus aureus and Bacillus megaterium. The minimum inhibitory concentration values of nicotinamidines against all tested microorganisms were in the range of 10–20 μM. In specific, compounds 4a and 4b showed excellent minimum inhibitory concentration values of 10 μM against Staphylococcus aureus bacterial strain and were similar to ampicillin as an antibacterial reference. On the other hand, selected nicotinamidine derivatives were biologically screened for their cytotoxic activities against a panel of 60 cell lines representing nine types of human cancer at a single high dose at National Cancer Institute, Bethesda, MD, USA. Nicotinamidines showing promising activities were further assessed in a five-dose screening assay to determine their compound concentration causing 50% growth inhibition of tested cell (GI(50)), compound concentration causing 100% growth inhibition of tested cell (TGI), and compound concentration causing 50% lethality of tested cell (LC(50)) values. Structure-activity relationship studies demonstrated that the activity of members of this series can be modulated from cytostatic to cytotoxic based on the substitution pattern/nature on the terminal phenyl ring. The most active compound was found to be 4e displaying a submicromolar GI(50) value of 0.83 μM, with TGI and LC(50) values of 2.51 and 100 μM, respectively. Finally, the possible underlying mechanism of action of this series of compounds was investigated by determining their nuclease-like DNA degradation ability in addition to their antioxidant power and all monocations proved to be effective in all assays. Dove Medical Press 2016-03-11 /pmc/articles/PMC4795586/ /pubmed/27042005 http://dx.doi.org/10.2147/DDDT.S102128 Text en © 2016 Youssef et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Youssef, Magdy M
Arafa, Reem K
Ismail, Mohamed A
Synthesis, antimicrobial, and antiproliferative activities of substituted phenylfuranylnicotinamidines
title Synthesis, antimicrobial, and antiproliferative activities of substituted phenylfuranylnicotinamidines
title_full Synthesis, antimicrobial, and antiproliferative activities of substituted phenylfuranylnicotinamidines
title_fullStr Synthesis, antimicrobial, and antiproliferative activities of substituted phenylfuranylnicotinamidines
title_full_unstemmed Synthesis, antimicrobial, and antiproliferative activities of substituted phenylfuranylnicotinamidines
title_short Synthesis, antimicrobial, and antiproliferative activities of substituted phenylfuranylnicotinamidines
title_sort synthesis, antimicrobial, and antiproliferative activities of substituted phenylfuranylnicotinamidines
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795586/
https://www.ncbi.nlm.nih.gov/pubmed/27042005
http://dx.doi.org/10.2147/DDDT.S102128
work_keys_str_mv AT youssefmagdym synthesisantimicrobialandantiproliferativeactivitiesofsubstitutedphenylfuranylnicotinamidines
AT arafareemk synthesisantimicrobialandantiproliferativeactivitiesofsubstitutedphenylfuranylnicotinamidines
AT ismailmohameda synthesisantimicrobialandantiproliferativeactivitiesofsubstitutedphenylfuranylnicotinamidines